Blue Horseshoe Stocks: JACK Update & More

Jack in the Box, Inc. JACK – Update

As a fresh options trading idea on Friday morning, we submitted the Jack 07/20 $80-90 Calls for observation after noticing the company’s solid earnings report and premarket gap-up. Although we passed over the weeklies for the July 20th calls for a bit more of an extended idea, it took no time at all for those contracts to see significant appreciation.

We’re pleased to say that each of the three selected targets produced respectable single-session moves, and will remain on our radar moving forward. Those potential gains were as follows: ,

$80 Calls – Range: 3.70-5.78 – Max Gain: 56%
$85 Calls – Range: 1.42-2.58 – Max Gain: 82%
$90 Calls – Range: .50-.80 – Max Gain: 60%


aTyr Pharma, Inc. LIFE

We noticed that LIFE woke from a slumber late last week, and began to trend off of its annual lows. We’re going to put it on the radar as a potential recovery play. As you can see, the stock was ridiculously oversold heading into last week, following a massive beating from roughly a month ago.

We believe there is a fair chance that the stock could return to the levels from prior to that backslide, which would spell significant gains from the current PPS.


Extended Watchlist:
AQMS, SRE, SNES, CODX, GNW, BIOC, TEUM, PTC

Blue Horseshoe Stocks: FIVE Recap & More

Five Below, Inc. FIVE – Options Recap

The fresh options idea we included in yesterday morning’s premarket report, the FIVE Weekly $90-95 Calls, was related to the company’s Q1 earnings report and strong guidance.

Unsurprisingly, those ideas provided us with solid chances for intraday profits as the stock ran from the $95 to the $100 range on the day. Be aware that despite the odd increments, the following are all of the contracts contained within our listed range. The moves they made were as follows:

$90 Calls – Range: 6.50-10.70 – Max Gain: 65%
$91 Calls – Range: 6.00-8.65 – Max Gain: 44%
$95 Calls – Range: 2.85-6.00 – Max Gain: 111%
____

Another Fresh Idea:
Jack in the Box JACK 07/20 $80-90 Calls


Axovant Sciences, Inc. AXON

This will be third consecutive day we’ve had to mention AXON, which we initially tagged on Wednesday morning following a large group of Form-4 buy on Tuesday. This insiders were obviously pre-informed about the news of an $840M+ licensing deal for AXON’s Parkinson’s gene therapy that would be released the following day.

Our sleuthing gave us a leg-up and our call was timed with precision. We observed a low of 3.27 on Tuesday and yesterday the stock saw a high of 6.59, which represents an excellent three-day swing of 102%


Extended Watchlist:
PAVM, CRMD, CEPU, CRMD, SDRL, HMNY

Blue Horseshoe Stocks: News Update, Options Highlights & More

Aperture Health, Inc. APRE – News Update

Our first order of business this morning is to update our readers on APRE, which we’ve been following for the better part of a month. In that time the stock has provided us with multiple swing trade opportunities and has been stretching the envelope on its latest upswing. From the .0188 swing-low we observed last Wednesday APRE has rapidly gained 219%, running up to a new high of .0599 yesterday.

We’ve pointed out a few key highlights of the current chart on the following snapshot:

We also want to point out some untraded-upon news that hit the wires yesterday post-market:

NEW YORK, May 12, 2016 /PRNewswire/ – Aperture Health, Inc. (OTC Markets.com: APRE) and CSS Alliance LLC (“CSS”), are pleased to announce that the company has branched out and signed a Joint Venture agreement which includes an exclusive worldwide distribution agreement with CSS Korea R&D Co., Ltd for new technologies and products that include solar powered A/C units, and powerless generators, as well as solar powered boilers (>>View Full PR)


Options Highlights

Jack in the Box, Inc. JACK - We had a couple of our active options targets turn up sizable opportunities for profits yesterday beginning with JACK 05/20 $70 and $75 Calls. We caught JACK on the heels of its Q2 earnings release, and various circumstances allowed for us to take advantage of the idea on its first day of mentioning.

The $70 Calls traded in an impressive range from a low of 2.25 on up 6.85 for an intraday gain of 204% The $75 Calls fared even better as they ran from .39 to 1.61, a single-session rip of 313% With performances like those, we’ll continue to track these contracts through to their expiration next week.

______

Macy’s Inc. M  – Our signaled range for Macy’s from Wednesday’s report added to its gains yesterday. We had been tracking the M Weekly $36-34 Puts. At the top of the range, the $36 Puts surged from a low of 1.83 up to 5.15, for a two-session swing of 181% Gains increased incrementally into the lower strike prices, culminating in the $34′s which traded up from Wednesday’s low of .50 to a new high of 3.62; a 624% swing.


Cerebain Biotech Corp. CBBT

Just after we were reviewing CBBT’s recent performance in yesterday’s morning report, (We’d added it to our radars last Tuesday) the stock went on to set another new high for us.

The stock traded in a daily range from 1.25-1.75, a respectable 40% intraday rip. From our observed low of .53, the new high represents an overall move of 230%


Extended Watchlist:
QUTR, IMMU, IDRA, XXII, NVDA, MOMO

Blue Horseshoe Stocks: Winning Options Plays & More

Options Recap

Both of our options ideas from yesterday’s morning report ended up providing us with a chance at sizable single-session gains.

Canadian Solar, Inc. CSIQ

We caught CSIQ in the unique position of having just registered a new 52-week low in the previous session, and having its earnings beat expectations yesterday, so jumping on CSIQ Weekly $16.50-18 Calls ended up being a sound strategy right from the outset. The impressive intraday moves were as follows:

$16.50 Calls – Trading Range: 1.20-1.76 – Max Gain: 47%
$17 Calls – Trading Range: .87-1.50 – Max Gain: 72%
$17.50 Calls– Trading Range: .30-.97 – Max Gain: 223%
$18 Calls – Trading Range: .27-.82 – Max Gain: 204%

Macy’s Inc. M

We went bearish on Macy’s yesterday, partly due to the overall downtrend the stock has seen in recent weeks, and as a reaction to yesterday morning’s disappointing earnings call. In this case our target range was the M Weekly $36-34 Puts and hefty gains were available across the board, including a big triple-bagger in the $34′s.

$36 Puts – Trading Range: 1.83-4.37  – Max Gain: 139%
$35.50 Puts – Trading Range: 1.40-3.79 – Max Gain: 171%
$35 Puts– Trading Range: 1.00-3.60 – Max Gain: 260%
$34.50 Puts – Trading Range: .83-2.88 – Max Gain: 247%
$34 Puts – Trading Range: .50-2.58 – Max Gain: 347%

_______

Fresh Ideas:  To throw some other options ideas into the mix this morning, we’re going to be adding Monsanto Co. MON Weekly $102-106 Calls and Jack in the Box, Inc. JACK 05/20 $70 and $75 Calls to our track-list.


Cerebain Biotech Corp. CBBT

We put CBBT on our radars last Tuesday after noticing some increased activity in the stock. Since our mention, subsequent to which we observed a low .53, we’ve seen a good bit of progress leading up to yesterday’s high of 1.25. That’s an overall move of 136%

The high came just prior to the closing bell, at which CBBT held a PPS of 1.20 so we’ll continue to monitor the situation carefully. We’ve had success recently with low-float, low-volume plays, and CBBT fits that bill to a tee.


Extended Watchlist:
FTPM, MRNA, BKCT, LXU, ZIOP, CCXI